In a significant development for the cannabis industry, U.S. health officials have recommended easing restrictions on cannabis and reclassifying it as a Schedule III drug under the Controlled Substances Act. The move could open the door to more cohesive payments systems in the sector. Currently,...
Food and Drug Administration (FDA) Deputy Commissioner for Food Policy and Response Frank Yiannas said the in-progress rule changes at the agency are likely to bring blockchain-based food tracking into existence, The Wall Street Journal (WSJ) reported Tuesday (Feb. 1). The FDA expects to complete...
August 30, 2023
In a significant development for the cannabis industry, U.S. health officials have recommended easing restrictions on cannabis and reclassifying it as a Schedule III drug under the Controlled Substances Act. The move could open the door to more cohesive payments systems in the sector. Currently, cannabis is classified as a Schedule I substance, which implies […]
February 01, 2022
Food and Drug Administration (FDA) Deputy Commissioner for Food Policy and Response Frank Yiannas said the in-progress rule changes at the agency are likely to bring blockchain-based food tracking into...
